Market Overview

Barrington Research Upgrades Anika Therapeutics to Outperform

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for ANIK

DateFirmActionFromTo
Jul 2018Barrington ResearchUpgradesMarket PerformOutperform
Jun 2018First AnalysisDowngradesOverweightEqual-Weight
May 2018Barrington ResearchUpgradesMarket PerformOutperform

View More Analyst Ratings for ANIK
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (ANIK)

TOP 3 Price Predictions For Bitcoin, Ethereum, Ripple: Altcoins Lose A Bullish Opportunity, But It Can't Last Forever...

Chesapeake's $2B Asset Sale Dissolves BofA's Bearish Thesis